CSNK2A1 confers gemcitabine resistance to pancreatic ductal adenocarcinoma via inducing autophagy
Open Access
- 28 January 2024
- journal article
- research article
- Published by Elsevier in Cancer Letters
- Vol. 585, 216640
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China
- Basic and Applied Basic Research Foundation of Guangdong Province
This publication has 51 references indexed in Scilit:
- Harnessing gemcitabine metabolism: a step towards personalized medicine for pancreatic cancerTherapeutic Advances in Medical Oncology, 2012
- E Platinum, a newly synthesized platinum compound, induces autophagy via inhibiting phosphorylation of mTOR in gastric carcinoma BGC-823 cellsToxicology Letters, 2012
- Inhibition of Casein kinase-2 induces p53-dependent cell cycle arrest and sensitizes glioblastoma cells to tumor necrosis factor (TNFα)-induced apoptosis through SIRT1 inhibitionCell Death & Disease, 2012
- CX-4945, an Orally Bioavailable Selective Inhibitor of Protein Kinase CK2, Inhibits Prosurvival and Angiogenic Signaling and Exhibits Antitumor EfficacyCancer Research, 2010
- Emergence of protein kinase CK2 as a key target in cancer therapyBioFactors, 2010
- Addiction to protein kinase CK2: A common denominator of diverse cancer cells?Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics, 2010
- Regulation of cell proliferation and survival: Convergence of protein kinases and caspasesBiochimica et Biophysica Acta (BBA) - Proteins and Proteomics, 2010
- Coordinated regulation of autophagy by p38α MAPK through mAtg9 and p38IPThe EMBO Journal, 2009
- The role of autophagy in cancer development and response to therapyNature Reviews Cancer, 2005
- A Potential Role of Nuclear Matrix-associated Protein Kinase CK2 in Protection against Drug-induced Apoptosis in Cancer CellsJournal of Biological Chemistry, 2001